Peak Bone Mass in Young HIV-Infected Patients Compared With Healthy ControlsEugènia Negredo, Bonaventura Clotet, Valentina Isernia et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2013Cited by 35
Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individualsEugènia Negredo, Bonaventura Clotet, Vicente Estrada et al.|Journal of Antimicrobial Chemotherapy|2016Cited by 11
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimensDaniel Podzamczer, Antonio Rivero, Arkaitz Imaz et al.|Journal of Antimicrobial Chemotherapy|2023Cited by 10